News

Filter

Current filters:

None

8401 to 8410 of 95882 results

South Korean govt to slash drug prices 14%

08-11-2011

South Korea’s Ministry of Health and Welfare has issued an advance notice of the legislation of…

Asia-PacificPharmaceuticalPoliticsPricingResearch

FDA accepts VIVUS NDA filing for Qnexa with PDUFA set for April 2012

08-11-2011

There was good news for US drugmaker VIVUS (Nasdaq: VVUS) in its long-running battle to get its weight-loss…

MetabolicsNorth AmericaPharmaceuticalQnexaRegulationVivus

Added indication for Bristol-Myers’ Erbitux approved by FDA

08-11-2011

The US Food and Drug Administration yesterday approved US drug major Bristol-Meyers Squibb’s (NYSE:…

Bristol-Myers SquibbErbituxNorth AmericaOncologyPharmaceuticalRegulation

Ph III study shows Novartis’ canakinumab substantially reduces steroid use in children with SJIA

08-11-2011

Swiss drug major Novartis (NOVN: VX) says new pivotal Phase III data show that 45% of children with active…

Anti-Arthritics/RheumaticsCanakinumab InjectionIlarisNovartisResearch

Vertex’ Incivek set to break record for fastest product launch

08-11-2011

Vertex Pharmaceuticals’ (Nasdaq: VRTX) new hepatitis C drug Incivek (telaprevir) is being touted…

FinancialIncivekMarkets & MarketingPharmaceuticalVertex

Novo Nordisk says DegludecPlus provides superior glycemic control vs Lantus

07-11-2011

Denmark-based insulin giant Novo Nordisk (NVO: N) yesterday announced positive clinical results from…

DegludecDegludecPlusDiabetesLantusNovo NordiskPharmaceuticalResearchSanofi

Small-molecule cancer drug revenues set to reach $27.3 billion in 2015, predicts Visiongain

07-11-2011

Rising disease prevalence, along with advances in pharmacotherapy and diagnostics, will stimulate the…

Markets & MarketingOncologyPharmaceutical

8401 to 8410 of 95882 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top